RxDoctor Payments Data

Kayla Slattery, NP

Family · Vincent, OHNPI 1871139592

Payments from drug & device makers

$682in general payments, 2019–2025

Across 35 payments — averaging $19.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$141
  • Exact Sciences$61
  • Boehringer Ingelheim$51
  • Amgen$50
  • Otsuka America Pharmaceutical, Inc.$43
  • Merck$36
  • plus $300 from 14 others

What the payments were for

  • Food & beverage$682100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$682 in reported general payments places this provider in the 60th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$41,406
Medicare patients
248
Services billed
654

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide41$44,360
MounjaroTirzepatide35$36,183
EliquisApixaban32$27,584
TrulicityDulaglutide16$14,857
VascepaIcosapent Ethyl19$10,168
AbrysvoRsv Vacc, Pref A And Pref B/Pf29$9,113
ShingrixVaricella-Zoster Ge/As01b/Pf38$8,316
Breo ElliptaFluticasone/Vilanterol11$5,987
SynthroidLevothyroxine Sodium18$1,465
Sucralfate22$1,401
Atorvastatin Calcium171$1,374
Lantus SolostarInsulin Glargine,hum.Rec.Anlog15$1,341
Metoprolol Succinate67$1,243
Butalb-Acetaminoph-Caff-CodeinButalbit/Acetamin/Caff/Codeine18$1,202
Pantoprazole Sodium64$1,174

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$13$51,04051 claims
Novo NordiskOzempic$30$44,36041 claims
PfizerEliquis, Abrysvo$34$36,69661 claims
GSKShingrix, Breo Ellipta$23$14,30349 claims
AbbVieSynthroid$15$1,46518 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 6,812 family providers in Ohio.

Other family in Vincent

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →